CytomX Therapeutics, Inc.

DEUTSCHE BANK AG\ CTMX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/6/2026

Shares

463,421

Value ($000)

2,178

Weight

0.0%

2018 Q2 - 2026 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/6/2026	2,178	0.0%	463,421	3/31/2026
2022 Q1	5/13/2022	102	0.0%	38,145	3/31/2022
2021 Q4	2/16/2022	183	0.0%	42,323	12/31/2021
2021 Q3	11/4/2021	203	0.0%	39,849	9/30/2021
2021 Q2	8/11/2021	257	0.0%	40,510	6/30/2021
2021 Q1	5/13/2021	320	0.0%	41,353	3/31/2021
2020 Q4	2/16/2021	572	0.0%	87,329	12/31/2020
2020 Q3	11/12/2020	777	0.0%	116,894	9/30/2020
2020 Q2	8/13/2020	507	0.0%	60,886	6/30/2020
2020 Q1	5/14/2020	410	0.0%	53,382	3/31/2020
2019 Q4	2/14/2020	1,476	0.0%	177,799	12/31/2019
2018 Q3	12/21/2021	3,725	—	201,308	9/30/2018
2018 Q2	4/21/2020	2,170	—	94,923	6/30/2018